The Science Behind Safe Blood at JOOTRH

“Why has the blood delayed yet my family members have already donated?” Erick Ochieng’ asked anxiously as he prepared for a skin-grafting procedure following severe injuries.

Like many families, Erick’s relatives believed that once blood was donated, it was immediately available for transfusion. What they did not know was that every unit must first undergo a rigorous scientific process to ensure it is safe for the patient who will receive it.

At Jaramogi Oginga Odinga Teaching and Referral Hospital (JOOTRH), this critical process has been strengthened by the introduction of a fully automated blood screening analyser, improving the speed, accuracy and reliability of testing.

The development is part of the hospital’s broader commitment to strengthening quality healthcare and patient safety under the visionary leadership of CEO Dr Joshua Okise.

According to Kenneth Onyango, a Medical Laboratory Technologist at JOOTRH, every donated unit is treated as potentially unsafe until laboratory testing confirms that it meets the required safety standards.

Blood is screened for transfusion-transmissible infections, including HIV, Hepatitis B, Hepatitis C and Syphilis. Any unit that tests positive is immediately discarded, regardless of the prevailing demand for blood.

This strict approach is critical because transfusing unsafe blood can expose patients to serious infections and complications.

But preparing blood for transfusion involves far more than screening for infections.

Each donation is collected in a sterile blood bag before undergoing blood grouping and RhD typing. The blood can then be separated into components such as red blood cells, plasma and platelets, allowing one donation to potentially benefit different patients depending on their medical needs.

The individual blood components are stored under a strictly monitored cold chain, with temperatures maintained at between 2°C and 6°C for appropriate blood products.

Before transfusion, compatibility testing, including crossmatching, is carried out to ensure the donor blood is compatible with the intended recipient.

It is this series of checks that explains why donated blood cannot simply move directly from a donor to a patient.

The automated analyser has significantly modernised the screening process at JOOTRH by replacing many manual procedures. Multiple samples can now be tested simultaneously, improving turnaround times while reducing the risk of human error.

For a major referral facility serving thousands of patients from Kisumu County and the wider Lake Region, such technological advancement is particularly important.

The investment in automation is not simply about speed. It is about building confidence in the safety and reliability of blood supplied to patients at one of the region’s leading referral hospitals.

Under Dr Okise’s leadership, JOOTRH continues to strengthen systems that support safe, efficient and patient-centred healthcare. The focus on technology, laboratory capacity and quality assurance reflects a wider understanding that modern healthcare requires strong systems behind every successful treatment.

Healthcare experts estimate that by the time one unit of blood has been collected, screened, processed, stored and safely transfused, the investment involved can range between KES 5,000 and KES 7,500.

The cost covers a range of essential services, including donor recruitment, laboratory reagents, equipment maintenance, cold-chain storage, compatibility testing, transfusion consumables and waste management.

This explains one of the common misconceptions surrounding blood transfusion.

Many people believe hospitals sell donated blood. In reality, the charges associated with transfusion largely relate to the extensive processing and safety measures required to make the donated blood suitable for a patient.

Under the Social Health Authority (SHA), eligible ward patients receive basic blood transfusion services free of charge or at a subsidised cost, subject to the applicable package and eligibility requirements.

The science behind safe blood is therefore a story of meticulous testing, technology, skilled professionals and strict quality controls.

For patients and their families, the waiting period can understandably be stressful, particularly when relatives have already donated blood and treatment is urgently required.

But as Erick’s experience demonstrates, the delay can sometimes reflect the very safeguards designed to protect the patient.

A unit of blood must be proven safe before it can be transfused.

At JOOTRH, the message is clear: donated blood is not simply collected and handed over. It goes through a carefully controlled journey in which science, technology and professional expertise work together to ensure that every unit meets safety requirements.

For Erick, what initially felt like an anxious delay was ultimately part of a system designed to protect his life.

Behind every safe blood transfusion is a chain of people, technology and procedures working quietly to ensure that the gift of blood fulfils its purpose.

And under the visionary leadership of Dr Joshua Okise, JOOTRH is strengthening that chain—putting patient safety, modern technology and quality healthcare at the centre of its mission to serve Kisumu and the wider Lake Region.